ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 106 filers reported holding ATHIRA PHARMA INC in Q2 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $37,436 | -72.1% | 2,773 | -73.1% | 0.00% | -50.0% |
Q4 2021 | $134,209 | +98.5% | 10,300 | +42.9% | 0.00% | +100.0% |
Q3 2021 | $67,620 | -43.8% | 7,209 | -38.7% | 0.00% | -50.0% |
Q2 2021 | $120,351 | -20.4% | 11,753 | +166.3% | 0.00% | 0.0% |
Q4 2020 | $151,180 | – | 4,414 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Logos Global Management LP | 1,630,744 | $21,249,000 | 2.19% |
VR Adviser, LLC | 1,000,000 | $13,030,000 | 1.78% |
ACUTA CAPITAL PARTNERS, LLC | 310,030 | $4,040,000 | 1.70% |
Ikarian Capital, LLC | 860,000 | $11,207,000 | 1.67% |
Bristlecone Advisors, LLC | 761,563 | $9,923,000 | 1.19% |
Perceptive Advisors | 6,851,832 | $89,280,000 | 0.69% |
DAFNA Capital Management LLC | 160,983 | $2,098,000 | 0.53% |
PATHSTONE FAMILY OFFICE, LLC | 1,442,247 | $18,792,000 | 0.47% |
Potomac Capital Management, Inc. | 40,000 | $521,000 | 0.46% |
RTW INVESTMENTS, LP | 1,906,557 | $24,842,000 | 0.36% |